# International Flavors & Fragrances Inc.  Share Price Target ‘$102.71’, now 6.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/international-flavors-fragrances-inc.share-price-target-102.71-now-6.8-upside-potential/4121168155
- Published: 2024-08-13T14:24:31+01:00
- Author: Charlotte Edwards

**International Flavors & Fragrances Inc.** which can be found using ticker (IFF)
have now 20 market analysts covering the stock. The analyst consensus now points
to a rating of ‘buy’. The range between the high target price and low target price
is between $116.00 and $77.00 with the average share target price sitting at $102.71.(
at the time of writing). Given that the stocks previous close was at $96.21 this
would indicate that there is a potential upside of 6.8%. Also worth taking note 
is the 50 day moving average now sits at $96.66 and the 200 day moving average is
$85.13. The company has a market capitalization of 24.49B. The stock price is currently
at: $95.78 USD

 The potential market cap would be $26,141,374,802 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $44.36 and
a 1.4% return on assets.

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage,
health and biosciences, scent and pharma solutions and complementary adjacent products.
The Company’s segments include Nourish, Health & Biosciences, Scent and Pharma Solutions.
The Nourish segment comprises of ingredients, flavors and food designs, with a diversified
portfolio across natural and plant-based specialty food ingredients, flavor compounds,
and savory solutions and inclusions. The Health & Biosciences comprises of health,
cultures and food enzymes, home and personal care, animal nutrition and grain processing.
The Scent segment comprises of fragrance compounds, including fine fragrances and
consumer fragrances; fragrance ingredients, and cosmetic active ingredients. The
Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-
based pharmaceutical excipients, used to improve the functionality and delivery 
of active pharmaceutical ingredients.

Share on: